Bloom Burton & Co.
20
35M
12
1.25
5
0.35
10
- Areas of investment
Summary
In 2008 was created Bloom Burton & Co., which is appeared as Corporate Investor. The main office of represented Corporate Investor is situated in the Toronto. The venture was found in North America in Canada.
The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2014. The higher amount of exits for fund were in 2015. This Bloom Burton & Co. works on 31 percentage points more the average amount of lead investments comparing to the other organizations. The real fund results show that this Corporate Investor is 0 percentage points less often commits exit comparing to other companies. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Bloom Burton & Co., startups are often financed by MaRS Investment Accelerator Fund, Jeff Chapleau, Genesys Venture. The meaningful sponsors for the fund in investment in the same round are GMP Securities, Cormark Securities Inc., RBC Capital Markets.
The fund has exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, Wellness. Among the most popular portfolio startups of the fund, we may highlight Knight Therapeutics, Profound Medical Inc, Newtopia.
Investments analytics
Analytics
- Total investments
- 20
- Lead investments
- 5
- Exits
- 10
- Rounds per year
- 1.25
- Follow on index
- 0.35
- Investments by industry
- Biotechnology (15)
- Health Care (11)
- Medical (8)
- Pharmaceutical (5)
- Therapeutics (5) Show 11 more
- Investments by region
-
- Canada (16)
- United States (3)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Avg. valuation at time of investment
- 73M
- Group Appearance index
- 0.75
- Avg. company exit year
- 37
- Avg. multiplicator
- 2.37
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Newtopia | 18 Oct 2016 | B2B, Health Care, Genetics, Gamification | Early Stage Venture | 10M | Canada, Ontario, Old Toronto |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.